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Introduction: Major depressive disorder (MDD) patients experience a systemic 
inflammatory stage. Monocytes play an important role in innate inflammatory responses 
and may be modulated by bacterial translocation. Our aim was to investigate the subset 
distribution and function of circulating monocytes, levels of proinflammatory cytokines, 
gut barrier damage, and bacterial translocation in MDD patients.
Methods: Twenty-two MDD patients without concomitant diseases and 14 sex- and 
age-matched healthy controls were studied. The levels of circulating CD14++CD16- 
(classical), CD14++CD16++ (intermediate) and CD14-CD16++ (nonclassical) monocytes 
and the intracytoplasmic tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and 
IL-10 expression in the presence or absence of lipopolysaccharide (LPS) stimulation 
were analyzed by polychromatic flow cytometry. The serum TNF-α, IL-1β, IL-6, and 
IL-10 levels were measured by Luminex. LPS-binding protein (LBP), intestinal fatty acid-
binding protein (I-FABP), and zonulin were measured by enzyme-linked immunosorbent 
assay (ELISA).
Results: MDD patients had a significant increase in the frequency of intermediate 
monocytes and a significant decrease in the frequency of classical monocytes compared 
to those in the healthy controls. MDD patients had a significantly increased percentage 
of classical monocytes that expressed IL-1β, intermediate monocytes that expressed 
IL-1β and IL6 and nonclassical monocytes that expressed IL-1β, and decreased levels of 
nonclassical monocytes that expressed IL6 compared to those in the healthy controls. 
MDD patients had significantly increased levels of circulating TNF-α, IL-1β, LBP, and 
I-FABP compared to those in the healthy controls. MDD patients with high LBP levels had 
a significant reduction in the number of circulating monocytes compared to that in the 
normal-LBP MDD patients, which can be mainly ascribed to a decrease in the number of 
intermediate and nonclassical monocytes.
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InTRODUCTIOn
Major depressive disorder (MDD) is a severe psychiatric disorder 
that is highly prevalent worldwide (1). MDD is currently ranked as 
the fourth-leading cause of disability and premature death in the 
world, and it is expected to become the second-leading contributor 
to overall disease burden by 2030 (2). Despite much progress has 
been made in understanding MDD, the pathogenesis is still largely 
unknown; however, the pathogenesis of MDD may be best described 
as a complex interplay of social, psychological and biological factors 
(3). Depression is associated with a chronic, low-grade inflammatory 
response and the activation of cell-mediated immunity, as well 
as the activation of the compensatory anti-inflammatory reflex 
system. MDD is similarly accompanied by increased oxidative and 
nitrosative stress, which contribute to the neuroprogression of the 
disorder. Among twenty-four studies that excluded any medical 
comorbidities, MDD was still associated with increased interleukin 
(IL)-6 and tumor necrosis factor (TNF)-α. There is strong support for 
the general hypothesis that inflammatory cytokines are significant 
elements in the pathogenesis of MDD (4, 5).
Monocytes mediate essential regulatory and effector 
functions in innate and adaptative immune inflammatory 
responses (6). Circulating monocytes are phenotypically and 
functionally heterogeneous and are divided into three major 
subsets based on the expression of the lipopolysaccharide (LPS) 
receptor CD14 and the FcγRIII low-affinity IgG receptor CD16: 
classical (CD14++CD16-), intermediate (CD14++CD16++), and 
nonclassical (CD14-CD16++) (7, 8). Activated monocytes show 
relevant immunomodulatory activities, including the secretion 
of pivotal cytokines, such as the proinflammatory cytokines 
IL-6, IL-1β, and tumor necrosis factor-alpha (TNF-α) and the 
anti-inflammatory cytokine IL-10 (9). Monocytes have been 
demonstrated to be involved in the pathogenesis of several 
organ-specific and systemic inflammatory diseases (10).
Different mechanisms may be involved in the regulation of the 
activation and survival of monocytes. It has been recently shown 
that damage to the intestinal barrier in MDD patients increases 
gut permeability and favors bacterial translocation (11). The 
passage of bacterial products such as LPS promotes a systemic 
inflammatory imbalance, including monocyte compromise (12). 
The hepatic synthesis of LPS-binding protein is induced by LPS, 
and in several clinical settings, plasma LBP reflects long-term 
exposure to bacteria and their endotoxins (13, 14).
Our work focused on the study of circulating monocytes and 
the level of bacterial translocation and gut barrier damage in MDD 
patients. To avoid confounding factors, we focused our study on 
a homogeneous population of 22 MDD patients without clinical 
infections or concomitant diseases that could have potential 
interactions with the immune system. In parallel, we studied 
14 age- and sex-matched healthy controls (HCs). We analyzed 
the pattern of the distribution of the classical, intermediate and 
nonclassical circulating monocyte subsets. We also investigated 
the intracytoplasmic production of TNF-α, IL-1β, IL-6, and IL-10 
after LPS stimulation and the serum levels of these cytokines. We 
measured the serum levels of LBP, I-FABP, and zonulin to study 
bacterial translocation and gut barrier integrity.
MATERIAls AnD METhODs
study Protocol
In this study, we included 22 patients with MDD from the 
Department of Psychiatry of the Clinica Universidad de Navarra 
and from the Hospital Universitario Príncipe de Asturias. The 
inclusion criteria included the following: (a) psychiatrist-
confirmed diagnosis of MDD, single or recurrent, according 
to the Diagnostic and Statistical Manual of Mental Disorders 
criteria, Fifth Edition (DSM-V) (15) (16); (b) a minimum 
score of 14 points on the 17-item Hamilton Rating Scale for 
Depression (HRSD); and (c) age, 18–65 years. Potential subjects 
were excluded for the following reasons: 1) acute infection in 
the last three months; 2) chronic bacterial or viral infection; 
3) the use of steroids or immunomodulatory drugs in the last 
three months; 4) an autoimmune disease; 5) a cardiovascular 
disease, including hypertension and ischemic heart disease; 
6) a hematopoietic, lung, hepatic or renal disorder; 7) an 
endocrine or metabolic disease, including diabetes mellitus 
and hypercholesterolemia, or a body-mass index (BMI) higher 
than 30; 8) a history of malignancy; 9) immunodeficiency and 
malnutrition; 10) pregnancy or lactation; and 11) concomitant 
psychiatric illness, as assessed with the MINI International 
Neuropsychiatric Interview (17). The patients were studied in 
parallel with 14 sex-, age-, and BMI-matched HCs from the 
same epidemiological area.
This study was approved by the ethics committee of the 
University of Navarra and the Hospital Universitario Príncipe 
Conclusions: We have demonstrated that compared to the healthy controls, MDD 
patients show a marked alteration in circulating monocytes, with an expansion of the 
intermediate subset with increased frequency of IL-1β and IL-6 producing cells. These 
patients also exhibited a systemic proinflammatory state, which was characterized by 
the enhanced serum TNF-α and IL-1β levels compared to those in the healthy controls. 
Furthermore, MDD patients showed increased LBP and I-FABP levels compared to those 
in healthy controls, indicating increased bacterial translocation and gut barrier damage.
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de Asturias. After the study procedures had been fully 
explained, the subjects provided written informed consent 
before study enrollment.
Blood samples were drawn from all subjects via standard 
venipuncture using an established aseptic technique. Samples 
were obtained from the MDD patients at the time of the 
clinical evaluation at the outpatient clinic. Serum samples were 
also included for analysis. After collection, the samples were 
centrifuged, and the serum was isolated, aliquoted, and stored 
at -80°C until analysis.
Isolation of Peripheral Blood Mononuclear 
Cells
Peripheral blood mononuclear cells (PBMCs) were separated with 
Ficoll-Hypaque (LymphoprepTM, Axis-Shield, Oslo, Norway) 
gradient centrifugation. The cells were then resuspended in 
RPMI 1640 (BioWhittaker Products, Verviers, Belgium) 
supplemented with 10% heat-inactivated fetal calf serum, 25 mM 
HEPES (BioWhittaker Products) and 1% penicillin-streptomycin 
(BioWhittaker Products). Cell counting was performed with 
conventional light microscopy using a Neubauer chamber 
following the criteria for trypan blue dead-cell exclusion. The 
viability of fresh PBMCs was evaluated by both trypan blue 
(light microscopy) and 7-aminoactinomycin D (7-AAD) (flow 
cytometry) exclusion.
Immunophenotype studies and 
Intracellular Cytokines
The proportions of monocyte subsets were determined in 
fresh PBMCs by seven-color polychromatic flow cytometry 
in a FACSAria II cytometer using FACSDiva software (Becton 
Dickinson, NJ, USA). To analyze the production of cytokines 
by PBMCs, 1 million of fresh PBMCs were cultured in ultralow 
attachment plates (Corning Incorporated, ME, USA) (1 ml of 
cells at 106 cells/ml) and incubated for 4 h at 37°C with 5% CO2. 
PBMC stimulation was performed by adding LPS (10 µg/ml, 
Sigma-Aldrich Chemistry, Spain) and monensin (50 µg/ml, 
Sigma). Next, the cells were labeled with CD14-PerCP and 
CD16-Alexa647 (Becton Dickinson) MoAbs and the vital dye 
Aqua-QD565. For intracytoplasmic staining, the cells were fixed 
and permeabilized (Fix and Perm, Caltag Laboratories), and 
cytokines were stained with IL-1β-FITC, IL-10-PE, IL-6-V505 
and TNF-α-Alexa700 (Becton Dickinson) MoAbs.
Quantification of serum Cytokines Using 
luminex
To study the concentrations of IL-6, IL-1β, TNF-α, and IL-10 
cytokines in the serum, the Milliplex MAP Kit (MERCK, Darmstadt, 
Germany) was employed using the protocol recommended 
by MERCK. The plate was read in a Luminex MAGPIX with 
xPONENT software. The concentration of each cytokine was 
calculated from the standard curve using mean fluorescence 
intensity (MFI) analysis with Analyst software (MERCK).
study of The Intestinal Barrier Integrity 
and Bacterial Translocation
To study intestinal barrier damage, an analysis of FABP and 
zonulin concentrations in the serum was performed by enzyme-
linked immunosorbent assay (ELISA). I-FABP was purchased 
from Hycult Biotech (Hycult Biotech, PA, USA), and zonulin was 
purchased from R&D Systems (R&D Systems, MN, USA). The 
tests were carried out according to the protocols provided in the 
kits. The plate was read in an iMark Microplate Reader at 450 nm 
with Microplate Manager Software (Thermo Fisher Scientific, 
MA, USA).
To study bacterial translocation, the concentration of LBP in 
the serum was measured by ELISA (Abnova, Taipei, Taiwan). We 
performed 1:800 dilutions of the samples from the MDD patients 
and HCs. The test was carried out according to the protocol 
provided in the kit. The plate was read in an iMark Microplate 
Reader at 450 nm with Microplate Manager Software (Thermo 
Fisher Scientific).
statistical Analysis
Comparisons between patients and HCs were performed using 
a nonparametric Mann–Whitney U test. Associations between 
variables were assessed with Spearman’s rank correlation 
coefficient by simple linear regression analyses. All calculations 
were performed using the Statistical Package for the Social 
Sciences (SPSS, version 22.0, Chicago, IL). Significance was set 
at p < 0.05.
The absolute number of circulating monocyte subsets was 
calculated by the percentage of each subpopulation in PBMCs 
determined by flow cytometry multiplied by the total number 
of monocytes per microliter measured by Beckman Coulter, Inc 
(Brea, CA, USA).
REsUlTs
Demographic Profile of Participants
Table 1 shows the demographic data and clinical characteristics 
of the 22 MDD patients and 14 HCs included in the study. No 
significant differences were found between MDD patients and 
HCs with respect to the variables that were studied, except for 
employment status. The patient group included 13 females and 
9 males, ranging from 18 to 56 years of age. The duration of 
their depressive episode before entering the study was 17.16  ± 
4.60 weeks. Thirteen patients (59.1%) had suffered at least one 
previous MDD episode. The mean value of the HRSD was 
16.54 ± 1.71.
All patients received pharmacological treatment at their 
doctor’s discretion: 2 (9.09%) were medication-free, 19 (86.36%) 
received antidepressant medications, 17 (77.27%) received 
anxiolytics or hypnotics, 5 (22.72%) received mood stabilizers, and 
6 (27.27%) received atypical antipsychotics. Nineteen (86.36%) 
received combination pharmacotherapy, consisting of at least 2 
different types of medication in 10 patients (45.45%) and of at least 
3 different types of medication in the other 9 patients (40.90%). 
None of the patients received electroconvulsive therapy (ECT).
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MDD Patients show an Expansion of The 
CD14++CD16++ Intermediate Monocyte 
subset
We studied the number of circulating monocytes and their 
subset distribution in patients with MDD and in sex- and age-
matched HCs. (Figure 1). There were no statistically significant 
differences in the number of total circulating monocytes between 
the MDD patients and HCs. But a significant increase in the 
number of intermediate monocytes was found in MDD patients 
with respect to HCs. However, MDD patients showed a marked 
redistribution of the subsets of the monocyte compartment, with 
a significant increase in the frequency of intermediate monocytes 
and a significant decrease in the frequency of classical monocytes 
compared to those found in the HCs. There were no significant 
differences in the frequency of the nonclassical subset between 
the MDD patients and HCs.
MDD Patients Exhibit Differential 
Abnormal Cytokine Production in The 
Monocyte subsets
We studied the intracellular expression of TNF-α, IL-1β, IL-6, 
and IL-10 in the total monocyte population and in the classical, 
intermediate and nonclassical monocyte subsets from MDD 
patients and HCs after LPS stimulation. Figure 2 shows the flow 
cytometry gating strategy and histograms of the intracellular 
IL-1β, TNF-α, IL-6, and IL-10 expression by total circulating 
monocytes and classic, intermediate and nonclassic subsets in 
a representative case of MDD. We found that the percentage of 
the total monocyte population that expressed IL-1β in MDD 
patients was significantly higher than that in healthy controls 
(Figure 3) Compared to the healthy controls, MDD patients also 
had a significantly increased percentages of classical monocytes 
that expressed IL-1β, intermediate monocytes that expressed 
IL-1β and IL-6, nonclassical monocytes that expressed IL-1β and 
decreased percentages of intermediate monocytes that express 
IL-10 and nonclassical monocytes that expressed IL-6.
Next, in both groups of subjects, we calculated the potential 
number of circulating monocytes that could express TNF-α, 
IL-1β, IL-6, and IL-10 by multiplying the number of the different 
monocyte subsets by the percentage of cells that express the 
analyzed cytokines after LPS stimulation in the defined monocyte 
subsets in both groups of subjects (Figure 4). We observed that 
the number of circulating intermediate monocytes that could 
express TNF-α, IL-1β, IL-6, and IL-10 was significantly increased 
in the MDD patients compared to those found in the HCs.
We studied the MFI of the intracellular expression of TNF-α, 
IL-1β, IL-6 and IL-10 in the total monocyte population and in 
TABlE 1 | Baseline characteristics.
MDD hC p value
socio-demographic
Age, mean (SD) 40,3 (8.9) 40,8 (10,5) 0.44
Sex (% female) 59.1 57,1 0.91
Currently employed and active n (%) 12 (54.5) 13 (92.9) <0.05
College degree n (%) 9 (40.9) 7 (50.0) 0.63
Past history
Family history of depression n (%) 10 (45.6) 7 (50.0) 0.79
Family history of other psychiatric 
disorder n (%)
8 (36.4) 5 (35.7) 0.97
health characteristics
BMI, mean (SD) 26.45 (4.04) 25.26 (3.87) 0.81
Smoking n (%)
-Never 14 (63.6) 8 (57.1)
-Occasionally 3 (13.6) 3 (21.4)
-Everyday 5 (22.7) 3 (21.4)
Drinking n (%)
-Never 7 (31.8) 3 (21.4)
-Occasionally 12 (54.5) 10 (71.4)
-Everyday 3 (13.6) 1 (7.1)
FIgURE 1 | Absolute number and frequency of total circulating monocytes and of the classical, intermediate and nonclassical monocyte subsets in MDD patients 
and healthy controls. Absolute number (cells/μl) (y axis) of circulating monocytes and of the classical, intermediate and nonclassical subsets in MDD patients (gray 
box plots) and healthy controls (white box plots) are shown in panel (A). Frequency of the three different monocyte subsets in the circulating monocytes in MDD 
patients (gray box plots) and controls (white box plots) are shown in panel (B). The top of the rectangle indicates the third quartile, the horizontal line near the middle 
of the rectangle indicates the median, and the bottom of the rectangle indicates the first quartile. A vertical line extends from the top of the rectangle to indicate the 
maximum value, and another vertical line extends from the bottom of the rectangle to indicate the minimum value. *Significant difference between MDD and healthy 
controls for the indicated variable.
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the classical, intermediate and nonclassical monocyte subsets 
from MDD patients and HCs after LPS stimulation (Figure 5). 
We found that the MFI of TNF-α and IL-6 expression on 
intermediate monocytes were significantly higher in the MDD 
patients than in HCs.
We also measured the circulating levels of the proinflammatory 
cytokines TNF-α, IL-1β, and IL-6 and the anti-inflammatory 
cytokine IL-10 in MDD patients and HCs (Figure 6). MDD 
patients had significantly increased levels of circulating TNF-α 
and IL-1β compared to those found in HCs. We detected IL-1β, 
IL6, and TNF-α in the 100% and IL10 in the 91% of the serum 
from patients. In serum form HCs, we detected IL-1β, and 
TNF-α in the 100% of the samples and Il6 and IL10 in the 91% 
of the serums. There were no significant correlations between the 
serum levels and the percentages of monocytes that expressed 
the analyzed cytokines (data not shown).
MDD Patients show Increased levels of 
Circulating lBP
We investigated the serum concentrations of LBP, I-FABP, 
and zonulin and in MDD patients and HCs (Figure 6). MDD 
FIgURE 2 | Dot plots represent the flow cytometry gating strategy and histograms of the intracellular IL-1β, TNF-α, IL-6 and IL-10 expression by total circulating 
monocytes and classical, intermediate and nonclassical subsets in a representative case of MDD. The first row dot plots represent the selected gates and 
percentages to obtain the total monocytes (panel A) and classical, intermediate and nonclassical monocyte subsets (panel B, C and D, respectively) in the presence 
or absence of LPS (5 ug/ml) stimulation for 4 hours (panel 1 and 2). Panel A, B, C and D. Histograms represent the percentages of TNF-α, IL-1β, IL-6 and IL-10-
producing monocyte in the indicated monocytes subsets.
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patients showed significantly increased levels of LBP and I-FABP 
compared to those found in HCs. We detected LBP, I-FABP, and 
zonulin in the 100% of the serum from patients. In serum form 
HCs, we found zonulin in the 100% and I-FABP in the 94% of 
the samples. However, we only found LBP in the 50% of serums 
from HCs.
We found that 7 (high-LBP MDD) out of the 22 MDD 
patients had LBP levels higher than the 95th percentile of 
those found in HCs. High-LBP MDD patients had significantly 
increased serum zonulin concentrations compared to those with 
normal LBP levels (Figure 7). In addition, we found a significant 
different monocyte subset distributions in both groups of MDD 
patients, with a significant increase in the percentage of classical 
monocytes and a decrease in the intermediate monocytes in high-
LBP MDD patients compared to those in normal-LBP MDD 
patients. However, we did not observe significant differences in 
the expression of TNF-α, IL-1β, IL-6, and IL-10 in the classical, 
intermediate and nonclassical monocyte subsets between both 
groups of MDD patients.
DIsCUssIOn
In this paper, we have demonstrated that compared to healthy 
controls, MDD patients show a marked disturbance of 
circulating monocytes, with the expansion of the intermediate 
subset with increased frequency of IL-1β and IL-6 producing 
cells. Concurrently, classical monocytes are decreased but 
have augmented frequency of IL-1β producing cells compared 
to those in the healthy controls. These patients also show a 
systemic proinflammatory state, characterized by enhanced 
serum TNF-α and IL-1β levels compared to those in the healthy 
controls. Furthermore, augmented circulating levels of LBP and 
I-FABP are found in MDD patients compared to those in healthy 
controls, indicating that these patients experience increased 
bacterial translocation and gut barrier damage.
The cause of MDD remains only partially defined. It is known 
that depression is coupled with the dysregulation of the immune-
inflammatory system (18–20). The relevance of the innate 
immune system in the pathogenesis of MDD has been proposed 
FIgURE 3 | Frequency of TNF-α, IL-1β, IL-6 and IL-10 expression by circulating monocytes and classical, intermediate and nonclassical monocytes in MDD patients 
and healthy controls after stimulation with LPS stimulation. Frequencies of cells (y axis) in MDD patients (gray box plots) and healthy controls (white box plots) that 
express the indicated cytokine (x axis) after in vitro LPS (5 ug/ml) stimulation for 4 hours in total (panel A), classical (panel B), intermediate (panel C) and nonclassical 
(panel D) monocytes. The top of the rectangle indicates the third quartile, the horizontal line near the middle of the rectangle indicates the median, and the bottom 
of the rectangle indicates the first quartile. A vertical line extends from the top of the the maximum value, and another vertical line extends from the bottom of the 
rectangle to indicate the minimum value. *Significant difference between MDD and healthy controls for the indicated variable.
November 2019 | Volume 10 | Article 812Frontiers in Psychiatry | www.frontiersin.org
Circulating Monocytes and Bacterial Translocation in MDDAlvarez-Mon et al.
7
(21–23). Monocytes are a cornerstone of the immune system 
that link innate and adaptive immunity and play critical roles 
in the response to bacterial infections and in the induction and 
regulation of the inflammatory response (6, 24). Our findings 
show that MDD patients have normal monocyte counts, which is 
consistent with previous reports (25–30). Circulating monocytes 
represent a versatile and dynamic cell population that is 
composed of different functionally heterogeneous subsets (7, 8). 
In MDD patients, our data demonstrate a marked redistribution 
of the circulating monocyte subsets, with an expansion of the 
intermediate monocytes and a decrease in classical monocytes 
compared to those of the healthy controls. These findings 
support the notion of the increased differentiation of classical to 
intermediate monocytes in MDD patients compared to that in 
healthy controls (24). Interestingly, the expansion of intermediate 
monocytes has been observed in various inflammatory diseases 
(31, 32). The prognostic value of the number of intermediate 
monocytes has also been shown for cardiovascular events in 
some chronic diseases (33–35). Furthermore, a reduction in 
classical monocytes has been previously described in chronic 
inflammatory diseases (36). Since the MDD patients included in 
our study did not suffer from inflammatory, cardiovascular or 
metabolic disorders, our findings support the hypothesis that 
the monocyte subset shifts found in MDD patients are not a 
consequence of comorbid somatic disorders.
Conflicting results regarding the classical and nonclassical 
monocyte subset frequencies have been previously described in 
MDD patients (25, 28, 29, 37). The differences in methodology 
and study populations may explain the observed discrepancies 
between earlier and current studies. Using a similar experimental 
methodology, our observations of the expansion and retraction 
of the intermediate monocytes and classical monocytes in MDD 
patients agree with recently published results (37). Furthermore, 
the percentage of nonclassical monocytes is normal in MDD 
patients. These findings give an explanation for the normal 
monocyte subset distribution in MDD patients with the 
simple analysis of two subsets, without the specific study of the 
intermediate and nonclassical monocytes (25, 28, 29). Differences 
in the somatic characteristics of the patients, such as age, BMI, 
the severity of the disease, and epidemiological characteristics, 
such as diet, might also be involved in the differences in the 
previous results.
FIgURE 4 | Circulating monocytes and classical, intermediate and nonclassical monocytes are able to express TNF-α, IL-1β, IL-6 and IL-10 in MDD patients and 
healthy controls. Absolute number (cells/μl) (y axis) of circulating monocytes (panel A) and of the classical (panel B), intermediate (panel C) and nonclassical (panel D) 
monocytes in MDD patients (gray box plots) and healthy controls (white box plots) that are able to express the indicated cytokine (x axis) after in vitro LPS (5 ug/ml) 
stimulation for 4 hours. The top of the rectangle indicates the third quartile, the horizontal line near the middle of the rectangle indicates the median, and the bottom 
of the rectangle indicates the first quartile. A vertical line extends from the top of the rectangle to indicate the maximum value, and another vertical line extends from 
the bottom of the rectangle to indicate the minimum value. *Significant difference between MDD and healthy controls for the indicated variable.
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In MDD patients, we also investigated the proinflammatory 
function of monocytes by analyzing the cellular TNF-α, IL-1β, 
IL-6, and IL-10 expression. Our results show that there is an 
abnormal pattern of proinflammatory cytokine expression by the 
monocyte subsets in MDD patients. The expanded intermediate 
monocytes show increased frequency of IL-1β and IL6 producing 
cells as wells as enhanced production of both cytokines. The 
classical and nonclassical monocytes show increased frequency 
of IL-1β producing cells, supporting a proinflammatory bias of 
these cells in MDD patients. In addition, nonclassical monocytes 
show decreased IL6 and TNF-α compared to those in the 
healthy controls. This functional heterogeneity and the different 
frequency of the three subsets affect the analysis of cytokine 
expression by circulating monocytes. Interestingly, in MDD 
patients, the production of IL1, IL6, and TNF by circulating 
immune cells has been described as being increased, normal 
or decreased compared to those in healthy controls (38–42). 
These conflicting results may be explained by the different 
cellular preparations, experimental models and measurement 
technologies employed, as well as the clinical characteristics of 
the MDD patients and controls who were analyzed. Our results 
clearly establish that the study of monocytes in MDD patients 
requires specific analysis at the subset level and gives some 
insight to aid in the understanding of the discrepancies among 
previous studies. The analysis of the whole monocyte population 
hides the quantitative and functional alterations found in the 
classical, intermediate and nonclassical subsets in MDD patients.
The levels of circulating cytokines and their potential relevance 
as clinical biomarkers have been extensively studied in MDD 
patients. The reported results are heterogeneous, but increases in 
the circulating concentrations of IL1, IL6 and/or TNF have been 
observed in two meta-analyses (43, 44). Consistent with previous 
studies, we found an increase in the inflammatory mediators IL-1β 
and TNF-α in MDD patients compared to those in healthy controls, 
but we observed normal IL-6 and IL-10 levels in MDD patients. 
The sources of the enhanced proinflammatory TNF-α and IL-1β 
levels appear to be complex. Several immune and nonimmune 
cells may produce IL-1β and TNF-α (45–47). It is possible to 
suggest that the increased frequency of IL-1β producing cells and 
the increased expression of this cytokine found in intermediate 
monocyte subset, might contribute to the increased serum levels 
of this cytokine found in MDD. Furthermore, the enhanced 
FIgURE 5 | Mean fluorescence intensity (MFI) TNF-α, IL-1β, IL-6 and IL-10 expression by LPS activated circulating monocytes and classical, intermediate and 
nonclassical monocyte subsets in MDD patients and HCs. MFI of indicated cytokines in total monocytes (panel A), classic (panel B), intermediate (panel C) and 
non-classic monocytes subsets (panel D after in vitro LPS (5 ug/ml) stimulation for 4 hours from MDD patients (grey box plots) and HCs (white box plots). The top 
of the rectangle indicates the third quartile, a horizontal line near the middle of the rectangle indicates the median, and the bottom of the rectangle indicates the first 
quartile. A vertical line extends from the top of the rectangle to indicate the maximum value, and another vertical line extends from the bottom of the rectangle to 
indicate the minimum value. *Significant difference between MDD and healthy controls in the indicated variable.
November 2019 | Volume 10 | Article 812Frontiers in Psychiatry | www.frontiersin.org
Circulating Monocytes and Bacterial Translocation in MDDAlvarez-Mon et al.
9
frequency of IL-1β producing cells by the classical and normal 
nonclassical subsets may also be involved. However, the normal 
TNF-α expression by the three monocyte subsets excludes these 
cells as being the cellular source of the increased serum levels of 
this cytokine that are found in MDD patients. However, these “ex 
vivo” results obtained after “in vitro” cellular activation may do 
not reflect what is happening “in vivo”. Several mechanisms may 
be involved in the pathogenesis of the proinflammatory monocyte 
abnormalities found in MDD patients. Our strategy of inclusion 
for the MDD patients excludes the potential pathogenic role of 
concomitant inflammatory, metabolic and organic diseases.
It has been shown that bacterial translocation is a cause of 
immune system stimulation and systemic inflammation (48). 
We investigated whether MDD patients suffer from bacterial 
translocation. The hepatic synthesis of LBP is promoted by 
LPS, and LPS-LBP complexes bind to CD14 on the monocyte 
surface. LBP peaks in the plasma 2 to 3 days after transient 
bacteremia or endotoxemia, and the levels remain increased 
up to 72 h later (49). Indeed, in several clinical settings, plasma 
LBP seems to better reflect long-term exposure to bacteria and 
their endotoxins than endotoxin itself (50). Our data show that 
as a group, MDD patients show increased LBP serum levels, in 
agreement with a recent observation and a previous finding of 
an increased plasma concentration of LPS in MDD patients (11, 
51). The clinical setting described here, with increased serum 
LBP levels in MDD patients, differs from that of sepsis and septic 
patients, in which massive, acute LPS exposure promotes very 
high LBP concentrations (52). This finding supports the notion 
of the pathogenic relevance of bacterial translocation in the 
damage of monocytes in MDD patients (53).
FIgURE 6 | Circulating serum levels of TNF-α, IL-1β, IL-6 and IL-10 and LBP, zonulin and IFABP in MDD patients and healthy controls. Serum concentrations (pg/μl) 
(y axis) of TNF-α, IL-1β, IL-6 and IL-10 (panel A), and LBP (ng/ml), zonulin (mg/ml) and I-FABP (pg/ml) (panel B) in MDD patients (gray box plots) and healthy controls 
(white box plots). The top of the rectangle indicates the third quartile, the horizontal line near the middle of the rectangle indicates the median, and the bottom of the 
rectangle indicates the first quartile. A vertical line extends from the top of the rectangle to indicate the maximum value, and another vertical line extends from the 
bottom of the rectangle to indicate the minimum value. *Significant difference between both groups of MDD patients for the indicated variable.
FIgURE 7 | Circulating serum levels of LBP, zonulin and I-FABP and frequency of total circulating monocytes and of the classical, intermediate and nonclassical 
monocyte subsets in high-LBP and normal-LBP MDD patients. Serum concentrations of LBP (ng/ml), zonulin (mg/ml) and I-FABP (pg/ml) (panel A), and frequencies 
of circulating monocytes and of the classical, intermediate and nonclassical subsets (y axis) (panel B) in high-LBP (gray box plots) and normal-LBP (white box plots) 
MDD patients. The top of the rectangle indicates the third quartile, the horizontal line near the middle of the rectangle indicates the median, and the bottom of the 
rectangle indicates the first quartile. A vertical line extends from the top of the rectangle to indicate the maximum value, and another vertical line extends from the 
bottom of the rectangle to indicate the minimum value. *Significant difference between MDD and healthy controls for the indicated variable.
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Several sources may be involved as the origin of this bacterial 
translocation found in MDD patients. However, our inclusion 
criteria exclude the existence of a concomitant or recent (at 
least three months prior to the study) bacterial infection. The 
so-called gut-brain axis, linking the emotional and cognitive 
brain centers with gastrointestinal function, has recently received 
substantial attention in relation to psychiatric disorders (54–56). 
We have investigated gut barrier damage in MDD patients by 
quantifying I-FABP and zonulin, which are validated peripheral 
blood markers of gut function (57, 58). We found increased 
serum I-FABP in MDD patients compared to that in the healthy 
controls. This finding supports the existence of a disturbance 
in the intestinal barrier integrity of MDD patients. It has been 
reported that increased intestinal permeability favors bacterial 
translocation (59); increased intestinal permeability has been 
suggested as a pathophysiological mechanism in metabolic 
disorders (60), rheumatoid disorders (61, 62) and HIV infection 
(63), all of which are conditions with a persistent inflammatory 
component and a heightened risk of depression (64–67). Although 
the cross-sectional design of the current study precludes any 
causal inferences, it is possible to suggest that gut barrier damage 
might play a critical role in the increased bacterial translocation 
found in MDD patients. Although any causal relationships 
have not yet been determined, our data support the notion that 
gastrointestinal alterations may actually cause the low-grade 
systemic inflammation found in MDD patients.
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